D.L. Carlson Investment Group’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
BBHC
D.L. Carlson Investment Group's NVS Position: Q2 2018 in Review
D.L. Carlson Investment Group sold out of Novartis (NVS) in Q2 2018, closing a stake of 61,988 shares — an estimated $4.49M sold.
D.L. Carlson Investment Group first reported a position in NVS in Q2 2013 and held it in 15 quarters. The position peaked at $6.3M in Q3 2017. 987 funds tracked by Wall St. Rank hold NVS as of Q2 2018.
- D.L. Carlson Investment Group reported no remaining Novartis position as of Q2 2018 after selling out during the quarter.
- D.L. Carlson Investment Group sold 61,988 Novartis shares in Q2 2018, an estimated $4.49M.
- D.L. Carlson Investment Group first reported a position in Novartis in Q2 2013 and held it in 15 quarters.
- D.L. Carlson Investment Group's Novartis position peaked at $6.3M in Q3 2017.
- 987 funds tracked by Wall St. Rank held Novartis as of Q2 2018.
Based on D.L. Carlson Investment Group's 13F filing for Q2 2018, filed 10 Aug 2018.